Relevant Research Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomised controlled trials Retatrutide for the treatment of obesity, obstructive sleep apnea, and knee osteoarthritis: rationale and design of the TRIUMPH registrational clinical trials Retatrutidea game changer in obesity pharmacotherapy Unleashing the power of retatrutide: a possible triumph over obesity Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomised phase 2a trial Retatrutide in type 2 diabetes mellitus and obesity: an overview
doi: 10.1210/jc.2017-02389 137 TanHMChinCMChuaCBGatchalianEKongkanandAMohCLet al
Some studies have found that iron overload is related to an increased incidence of cancers, while others have reported that iron overload does not affect cancer development
de Herder, W
Your clinician reviews history, medications, and goals to determine suitability
doi:10.1002/jor.21107 Evidence-Base Disclosure The published evidence base for BPC-157 consists predominantly of preclinical research animal models (often rats or mice) and in vitro cell-culture experiments
